Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 7118

1.

A review of the efficacy of smoking-cessation pharmacotherapies in nonwhite populations.

Robles GI, Singh-Franco D, Ghin HL.

Clin Ther. 2008 May;30(5):800-12. doi: 10.1016/j.clinthera.2008.05.010. Review.

PMID:
18555928
2.

Varenicline: a first-line treatment option for smoking cessation.

Garrison GD, Dugan SE.

Clin Ther. 2009 Mar;31(3):463-91. doi: 10.1016/j.clinthera.2009.03.021. Review.

PMID:
19393839
3.

Safety and efficacy of the nicotine patch and gum for the treatment of adolescent tobacco addiction.

Moolchan ET, Robinson ML, Ernst M, Cadet JL, Pickworth WB, Heishman SJ, Schroeder JR.

Pediatrics. 2005 Apr;115(4):e407-14.

PMID:
15805342
4.

Late-term smoking cessation despite initial failure: an evaluation of bupropion sustained release, nicotine patch, combination therapy, and placebo.

Jamerson BD, Nides M, Jorenby DE, Donahue R, Garrett P, Johnston JA, Fiore MC, Rennard SI, Leischow SJ.

Clin Ther. 2001 May;23(5):744-52.

PMID:
11394732
5.

Outcomes from an outpatient smoking-cessation clinic.

Roth MT, Andrus MR, Westman EC.

Pharmacotherapy. 2005 Feb;25(2):279-88.

PMID:
15767242
7.

Triple-combination pharmacotherapy for medically ill smokers: a randomized trial.

Steinberg MB, Greenhaus S, Schmelzer AC, Bover MT, Foulds J, Hoover DR, Carson JL.

Ann Intern Med. 2009 Apr 7;150(7):447-54.

PMID:
19349630
8.

Does menthol attenuate the effect of bupropion among African American smokers?

Okuyemi KS, Ahluwalia JS, Ebersole-Robinson M, Catley D, Mayo MS, Resnicow K.

Addiction. 2003 Oct;98(10):1387-93.

PMID:
14519175
9.

Nicotine patch therapy in adolescent smokers.

Smith TA, House RF Jr, Croghan IT, Gauvin TR, Colligan RC, Offord KP, Gomez-Dahl LC, Hurt RD.

Pediatrics. 1996 Oct;98(4 Pt 1):659-67.

PMID:
8885942
10.

A 12-week double-blind, placebo-controlled study of bupropion sr added to high-dose dual nicotine replacement therapy for smoking cessation or reduction in schizophrenia.

Evins AE, Cather C, Culhane MA, Birnbaum A, Horowitz J, Hsieh E, Freudenreich O, Henderson DC, Schoenfeld DA, Rigotti NA, Goff DC.

J Clin Psychopharmacol. 2007 Aug;27(4):380-6.

PMID:
17632223
11.

Predictors of smoking cessation among African-Americans enrolled in a randomized controlled trial of bupropion.

Harris KJ, Okuyemi KS, Catley D, Mayo MS, Ge B, Ahluwalia JS.

Prev Med. 2004 Apr;38(4):498-502.

PMID:
15020185
12.

Nicotine patch therapy in 101 adolescent smokers: efficacy, withdrawal symptom relief, and carbon monoxide and plasma cotinine levels.

Hurt RD, Croghan GA, Beede SD, Wolter TD, Croghan IT, Patten CA.

Arch Pediatr Adolesc Med. 2000 Jan;154(1):31-7.

PMID:
10632247
13.

Nicotine replacement therapy for smoking cessation.

Silagy C, Mant D, Fowler G, Lancaster T.

Cochrane Database Syst Rev. 2000;(3):CD000146. Review. Update in: Cochrane Database Syst Rev. 2001;(3):CD000146.

PMID:
10908462
14.

Individualizing nicotine replacement therapy for the treatment of tobacco dependence: a randomized trial.

Lerman C, Kaufmann V, Rukstalis M, Patterson F, Perkins K, Audrain-McGovern J, Benowitz N.

Ann Intern Med. 2004 Mar 16;140(6):426-33.

PMID:
15023708
16.

Bupropion for smoking cessation in African American light smokers: a randomized controlled trial.

Cox LS, Nollen NL, Mayo MS, Choi WS, Faseru B, Benowitz NL, Tyndale RF, Okuyemi KS, Ahluwalia JS.

J Natl Cancer Inst. 2012 Feb 22;104(4):290-8. doi: 10.1093/jnci/djr513. Epub 2012 Jan 25.

17.
18.
19.

Treating nondepressed smokers with alcohol dependence in sustained full remission: nicotine patch therapy tailored to baseline serum cotinine.

Hurt RD, Patten CA, Offord KP, Croghan IT, Decker PA, Morris RA, Hays JT.

J Stud Alcohol. 2005 Jul;66(4):506-16.

PMID:
16240558
20.

Bupropion SR for smoking cessation in smokers with cardiovascular disease: a multicentre, randomised study.

Tonstad S, Farsang C, Klaene G, Lewis K, Manolis A, Perruchoud AP, Silagy C, van Spiegel PI, Astbury C, Hider A, Sweet R.

Eur Heart J. 2003 May;24(10):946-55.

PMID:
12714026

Supplemental Content

Support Center